This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Curagen Corporation. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Suresh G Shenoy: Innovator in Biotech
Introduction
Suresh G Shenoy is a notable inventor based in Branford, CT (US). He has made significant contributions to the field of biotechnology, particularly in the area of proteins and nucleic acids. With a total of 2 patents, his work has implications for therapeutic and diagnostic methods.
Latest Patents
Shenoy's latest patents include innovations related to proteins and polynucleotides encoding them. The first patent discloses nucleic acid sequences that encode novel polypeptides. It also details the polypeptides encoded by these sequences, along with antibodies that specifically bind to the polypeptide. Additionally, the invention outlines therapeutic, diagnostic, and research methods for the diagnosis, treatment, and prevention of disorders involving these novel human nucleic acids and proteins. The second patent similarly focuses on nucleic acid sequences and their encoded polypeptides, emphasizing their potential applications in various medical fields.
Career Highlights
Throughout his career, Suresh G Shenoy has worked with prominent companies in the biotechnology sector, including Curagen Corporation and Celidex Therapeutics, Inc. His experience in these organizations has contributed to his expertise and innovative capabilities in the field.
Collaborations
Shenoy has collaborated with several professionals, including Stacie Casman and Ferenc L Boldog. These partnerships have likely enhanced his research and development efforts, leading to impactful inventions.
Conclusion
Suresh G Shenoy's contributions to biotechnology through his patents and collaborations highlight his role as an innovator in the field. His work continues to influence therapeutic and diagnostic advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
